SHARE CAPITAL (Tables)
|
9 Months Ended |
12 Months Ended |
Sep. 30, 2021 |
Dec. 31, 2020 |
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
| Schedule of stock options activity |
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding |
|
|
|
|
Weighted |
|
Weighted |
|
|
|
|
|
|
|
Average |
|
Average |
|
|
|
|
|
Number of |
|
Exercise |
|
Remaining |
|
Aggregate |
|
|
Shares Subject |
|
Price Per |
|
Contractual |
|
Intrinsic Value |
|
|
to Options |
|
Share |
|
Life (in years) |
|
(in thousands) |
Balance at December 31, 2020 |
|
748,600 |
|
$ |
5.25 |
|
4.00 |
|
|
|
Options granted |
|
348,000 |
|
|
5.33 |
|
|
|
|
|
Options exercised |
|
(3,000) |
|
|
6.40 |
|
|
|
|
|
Options canceled / expired |
|
(79,500) |
|
|
5.96 |
|
|
|
|
|
Balance at September 30, 2021 |
|
1,014,100 |
|
|
5.16 |
|
3.62 |
|
$ |
2,670 |
Vested and exercisable at September 30, 2021 |
|
636,008 |
|
|
4.93 |
|
3.39 |
|
$ |
1,894 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding |
|
|
|
|
Weighted |
|
Weighted |
|
|
|
|
|
|
|
Average |
|
Average |
|
|
|
|
|
Number of |
|
Exercise |
|
Remaining |
|
Aggregate |
|
|
Shares Subject |
|
Price Per |
|
Contractual |
|
Intrinsic Value |
|
|
to Options |
|
Share |
|
Life (in years) |
|
(in thousands) |
Balance at December 31, 2018 |
|
3,335,000 |
|
$ |
0.48 |
|
|
|
|
|
Options granted |
|
1,501,000 |
|
$ |
1.56 |
|
|
|
|
|
Options exercised |
|
(650,000) |
|
$ |
0.15 |
|
|
|
|
|
Options canceled / expired |
|
(1,000,000) |
|
$ |
0.05 |
|
|
|
|
|
Balance at December 31, 2019 |
|
3,186,000 |
|
$ |
1.12 |
|
4.62 |
|
|
|
Options granted |
|
865,000 |
|
$ |
0.95 |
|
|
|
|
|
Options exercised |
|
(50,000) |
|
$ |
0.50 |
|
|
|
|
|
Options canceled / expired |
|
(258,000) |
|
$ |
1.60 |
|
|
|
|
|
Balance at December 31, 2020 |
|
3,743,000 |
|
$ |
1.05 |
|
4.00 |
|
$ |
1,053 |
Vested and exercisable at December 31, 2020 |
|
2,352,601 |
|
$ |
0.95 |
|
3.98 |
|
$ |
995 |
|
| Schedule of stock options outstanding and exercisable |
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding |
|
Options Exercisable |
|
|
Weighted |
|
|
|
|
|
|
|
|
Average |
|
Weighted |
|
|
|
Weighted |
|
|
Remaining |
|
Average |
|
|
|
Average |
Number of |
|
Contractual |
|
Exercise Price |
|
Number |
|
Exercise Price |
Outstanding |
|
Life (in years) |
|
Per Share |
|
Exercisable |
|
Per Share |
200,000 |
|
3.90 |
|
$ |
0.25 |
|
200,000 |
|
$ |
0.25 |
12,000 |
|
1.07 |
|
$ |
14.00 |
|
12,000 |
|
$ |
14.00 |
15,000 |
|
6.30 |
|
$ |
9.00 |
|
15,000 |
|
$ |
9.00 |
85,000 |
|
2.00 |
|
$ |
9.00 |
|
73,667 |
|
$ |
9.00 |
146,800 |
|
2.30 |
|
$ |
7.80 |
|
127,227 |
|
$ |
7.80 |
81,300 |
|
3.01 |
|
$ |
6.40 |
|
48,780 |
|
$ |
6.40 |
40,000 |
|
3.91 |
|
$ |
4.50 |
|
18,667 |
|
$ |
4.50 |
93,000 |
|
4.20 |
|
$ |
4.85 |
|
31,000 |
|
$ |
4.85 |
311,000 |
|
4.34 |
|
$ |
5.30 |
|
103,667 |
|
$ |
5.30 |
30,000 |
|
4.54 |
|
$ |
5.60 |
|
6,000 |
|
$ |
5.60 |
1,014,100 |
|
3.62 |
|
$ |
5.16 |
|
636,008 |
|
$ |
4.93 |
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding |
|
Options Exercisable |
|
|
Weighted |
|
|
|
|
|
|
|
|
Average |
|
Weighted |
|
|
|
Weighted |
|
|
Remaining |
|
Average |
|
|
|
Average |
Number of |
|
Contractual |
|
Exercise Price |
|
Number |
|
Exercise Price |
Outstanding |
|
Life (in years) |
|
Per Share |
|
Exercisable |
|
Per Share |
1,000,000 |
|
4.65 |
|
$ |
0.05 |
|
1,000,000 |
|
$ |
0.05 |
60,000 |
|
1.82 |
|
$ |
2.80 |
|
60,000 |
|
$ |
2.80 |
75,000 |
|
7.05 |
|
$ |
1.80 |
|
75,000 |
|
$ |
1.80 |
425,000 |
|
2.75 |
|
$ |
1.80 |
|
311,667 |
|
$ |
1.80 |
884,000 |
|
3.04 |
|
$ |
1.56 |
|
530,401 |
|
$ |
1.56 |
434,000 |
|
3.76 |
|
$ |
1.28 |
|
202,533 |
|
$ |
1.28 |
300,000 |
|
4.66 |
|
$ |
0.90 |
|
60,000 |
|
$ |
0.90 |
565,000 |
|
4.95 |
|
$ |
0.97 |
|
113,000 |
|
$ |
0.97 |
3,743,000 |
|
4.00 |
|
$ |
1.05 |
|
2,352,601 |
|
$ |
0.95 |
|
| Schedule of assumptions were used to determine fair value of the awards |
|
|
|
|
|
|
|
|
Nine Months Ended September 30, |
|
|
|
2021 |
|
2020 |
|
Expected life (in years) |
|
5.0 |
|
5.0 |
|
Risk-free interest rate |
|
0.4 |
% |
3.0 |
% |
Dividend yield |
|
— |
% |
— |
% |
Expected volatility |
|
91 |
% |
107 |
% |
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
2020 |
|
2019 |
|
Expected life (in years) |
|
5.0 |
|
5.0 |
|
Risk-free interest rate |
|
0.4-2.5 |
% |
2.0 |
% |
Dividend yield |
|
— |
% |
— |
% |
Expected volatility |
|
91-107 |
% |
100 |
% |
|
| Schedule of changes in stock option liability |
|
|
|
|
|
Balance at December 31, 2018 |
|
$ |
246 |
Loss on revaluation |
|
|
8 |
Reclassification option fair value at exercise to equity |
|
|
(188) |
Balance at December 31, 2019 |
|
$ |
66 |
Gain on revaluation |
|
|
(50) |
Balance at December 31, 2020 |
|
$ |
16 |
|
| Schedule of warrants |
|
|
|
|
|
Number of Warrants outstanding |
Balance at December 31, 2020 |
|
3,665,006 |
Debenture, warrants issued (Note 4) |
|
275,000 |
Balance at September 30, 2021 |
|
3,940,006 |
|
|
|
|
|
|
Number of Warrants outstanding |
Balance at December 31, 2018 |
|
49,000 |
Warrants exercised |
|
(44,600) |
Warrants expired |
|
(4,400) |
Convertible debt, warrants issued (Note 8) |
|
392,755 |
Balance at December 31, 2019 |
|
392,755 |
Convertible debt, warrants issued (Note 8) |
|
1,511,609 |
Equity financing, warrants issued (discussed above) |
|
16,420,664 |
Balance at December 31, 2020 |
|
18,325,028 |
|
| Schedule of average exercise price of the outstanding warrants |
|
|
|
|
|
Balance at December 31, 2018 |
|
$ |
56 |
Loss on revaluation |
|
|
14 |
Reclassification warrant fair value at exercise to equity |
|
|
(70) |
Balance at December 31, 2019 |
|
$ |
— |
|
| Schedule of warrants, valuation assumptions |
|
|
|
|
|
|
|
|
|
|
|
Year Ended |
|
Year Ended |
|
|
|
December 31, 2020 |
|
December 31, 2019 |
|
Risk free rate of return |
|
|
0.39 |
% |
|
1.64 |
% |
Expected life |
|
|
5.0 |
years |
|
4.0 |
years |
Expected volatility |
|
|
90 |
% |
|
171 |
% |
Expected dividend per share |
|
|
nil |
|
|
nil |
|
Exercise price |
|
$ |
0.78 |
|
$ |
1.40 |
|
Stock price |
|
$ |
0.96 |
|
$ |
1.31 |
|
|
| Consultant [Member] |
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
| Schedule of assumptions were used to determine fair value of the awards |
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
2020 |
|
|
2019 |
|
Risk free rate of return |
|
0.1 |
% |
|
1.7 |
% |
Expected life |
|
1.8 |
years |
|
2.8 |
years |
Expected volatility |
|
100 |
% |
|
170 |
% |
Expected dividend per share |
|
nil |
|
|
nil |
|
|